National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 6) (No. PB 36 of 2013) (Cth)

Case

PB 36 of 2013

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 6)

National Health Act 1953

___________________________________________________________________________

I, Steve Dunlop, Acting Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated  13 June 2013

STEVE DUNLOP

Acting Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.6).

(2)This Instrument may also be cited as PB 36 of 2013.

2             Commencement

This Instrument commences on 1 July 2013.

3              Amendments to PB 79 of 2011

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1                   Amendments

  1. Section 3, Definition for diluent fee

omit:                    $4.83

substitute:          $4.91

  1. Section 3, Definition for dispensing fee

omit:                    $6.52

substitute:          $6.63

  1. Section 3, Definition for distribution fee

omit:                    $24.38

substitute:          $24.79

  1. Section 3 Definition for preparation fee

omit:                    $40.64

substitute:          $101.33

  1. Schedule 1 Part 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL with manner of administration Injection/intravesical:

omit:

Epirubicin SZ HX MP D
  1. Schedule 1 Part 1, entry for Irinotecan in the form I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL with manner of administration Injection:

omit:

Irinotecan SZ HX MP C3184 D

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.

See

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0